Owner Novartis AG

Inventors Voliva, Charles; Smith, Aaron; Bartulis, Sarah; Burger, Matthew; Pick, Teresa; Han, Wooseok; Hendrickson, Tom; Atallah, Gordana; Zhang, Yanchen; Iwanowicz, Ed; Verhagen, Joelle; Bruce, Ian; Liu, Jie; Levine, Barry; Merritt, Hanne; Ni, Zhi-Jie; Costales, Abran; Lan, Jiong; Menezes, Daniel; Dale, James; Legrand, Darren Mark; Frazier, Kelly; Knapp, Mark; Wiesmann, Marion; Pecchi, Sabina

Agent FB Rice

Pub. Number AU-A-2007214462

PCT Pub. Number WO2007/095588

Priority 60/876,729 22.12.06 US; 60/773,476 14.02.06 US

Filing date 14 February 2007

Wipo publication date 23 August 2007

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/437 (2006.01)

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups